dermatan sulfate has been researched along with Injury, Ischemia-Reperfusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, N; Kohmura, H; Okajima, K; Tomita, T; Uchiba, M | 1 |
| Makhoul, RG; Sobel, M; Sternbergh, WC | 1 |
2 other study(ies) available for dermatan sulfate and Injury, Ischemia-Reperfusion
| Article | Year |
|---|---|
Danaparoid sodium reduces ischemia/reperfusion-induced liver injury in rats by attenuating inflammatory responses.
Topics: Animals; Calcitonin Gene-Related Peptide; Chondroitin Sulfates; Dermatan Sulfate; Epoprostenol; Ganglia, Spinal; Heparitin Sulfate; Inflammation; Liver; Male; Neurons, Afferent; Rats; Rats, Wistar; Regional Blood Flow; Reperfusion Injury | 2007 |
Heparinoids with low anticoagulant potency attenuate postischemic endothelial cell dysfunction.
Topics: Acute Disease; Animals; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Dextran Sulfate; Endothelium, Vascular; Heparin; Heparitin Sulfate; Hindlimb; In Vitro Techniques; Ischemia; Male; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Vasodilation | 1995 |